In chronic myeloid leukemia (CML), overexpression of NLRP1 gene is associated with the promotion of proliferation and reduction of apoptosis in CML cells, in addition to inducing resistance to imatinib34. The gene discussed is NLRP1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.